HCID 66854087, compound → HCID 66853176, compound
Reaction equation
[CH:1]1([NH:4][C:5]([C:7]2[CH:8]=[N:9][N:10]3[CH:15]=[CH:14][C:13]([N:16]4[CH2:20][CH2:19][CH2:18][C@@H:17]4[C:21]4[CH:26]=[C:25]([F:27])[CH:24]=[C:23]([O:28][CH2:29][CH:30]5[CH2:34][O:33]C(C)(C)[O:31]5)[CH:22]=4)=[N:12][C:11]=23)=[O:6])[CH2:3][CH2:2]1>O1CCOCC1.Cl.CCN(C(C)C)C(C)C>[CH:1]1([NH:4][C:5]([C:7]2[CH:8]=[N:9][N:10]3[CH:15]=[CH:14][C:13]([N:16]4[CH2:20][CH2:19][CH2:18][C@@H:17]4[C:21]4[CH:26]=[C:25]([F:27])[CH:24]=[C:23]([O:28][CH2:29][CH:30]([OH:31])[CH2:34][OH:33])[CH:22]=4)=[N:12][C:11]=23)=[O:6])[CH2:3][CH2:2]1Participants
5
Reactant 1
Product 1
Reagents, catalysts & solvents 3
Procedure
A solution of N-cyclopropyl-5-((2R)-2-(3-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (Example 206, 30 mg, 0.061 mmol) in dioxane (0.5 mL) was charged with two drops of 6N HCl and shaken for two minutes. DIEA (5 drops) was added and the mixture directly purified by reverse phase column chromatography (0-50% acetonitrile/water) to afford N-cyclopropyl-5-((2R)-2-(3-(2,3-dihydroxypropoxy)-5-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (23 mg, 83% yield) as a clear film. MS (apci) m/z=456.1 (M+H).
Workup
- customthe mixture directly purified by reverse phase column chromatography (0-50% acetonitrile/water)
Sources & evidence
- ORD record
- ord-19a7b1292e704126af2657088135e1c2
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08791123B2
Reaction notes
Loading…